|
1
|
Cameron AM: Screening for viral hepatitis
and hepatocellular cancer. Surg Clin North Am. 95:1013–1021. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tomizawa M, Kondo F and Kondo Y: Growth
patterns and interstitial invasion of small hepatocellular
carcinoma. Pathol Int. 45:352–358. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tsujikawa H, Masugi Y, Yamazaki K, Itano
O, Kitagawa Y and Sakamoto M: Immunohistochemical molecular
analysis indicates hepatocellular carcinoma subgroups that reflect
tumor aggressiveness. Hum Pathol. 50:24–33. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tomizawa M, Garfield S, Factor V and
Xanthopoulos KG: Hepatocytes deficient in CCAAT/enhancer binding
protein alpha (C/EBP alpha) exhibit both hepatocyte and biliary
epithelial cell character. Biochem Biophys Res Commun. 249:1–5.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yamasaki H, Sada A, Iwata T, Niwa T,
Tomizawa M, Xanthopoulos KG, Koike T and Shiojiri N: Suppression of
C/EBP alpha expression in periportal hepatoblasts may stimulate
biliary cell differentiation through increased Hnf6 and Hnf1b
expression. Development. 133:4233–4243. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tomizawa M, Wang YQ, Ebara M, Saisho H,
Watanabe K, Nakagawara A and Tagawa M: Decreased expression of the
CCAAT/enhancer binding protein alpha gene involved in hepatocyte
proliferation in human hepatocellular carcinomas. Int J Mol Med.
9:597–600. 2002.PubMed/NCBI
|
|
7
|
Zaret KS and Carroll JS: Pioneer
transcription factors: Establishing competence for gene expression.
Genes Dev. 25:2227–2241. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Guye P, Ebrahimkhani MR, Kipniss N,
Velazquez JJ, Schoenfeld E, Kiani S, Griffith LG and Weiss R:
Genetically engineering self-organization of human pluripotent stem
cells into a liver bud-like tissue using Gata6. Nat Commun.
7:102432016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Takayama K, Inamura M, Kawabata K,
Sugawara M, Kikuchi K, Higuchi M, Nagamoto Y, Watanabe H, Tashiro
K, Sakurai F, et al: Generation of metabolically functioning
hepatocytes from human pluripotent stem cells by FOXA2 and HNF1α
transduction. J Hepatol. 57:628–636. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Takahashi K, Tanabe K, Ohnuki M, Narita M,
Ichisaka T, Tomoda K and Yamanaka S: Induction of pluripotent stem
cells from adult human fibroblasts by defined factors. Cell.
131:861–872. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tomizawa M, Shinozaki F, Motoyoshi Y,
Sugiyama T, Yamamoto S and Ishige N: Niclosamide suppresses
migration of hepatocellular carcinoma cells and downregulates
matrix metalloproteinase-9 expression. Oncol Lett. 10:3515–3518.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Davies B and Fried M: The L19 ribosomal
protein gene (RPL19): Gene organization, chromosomal mapping, and
novel promoter region. Genomics. 25:372–380. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tam S, Clavijo A, Engelhard EK and
Thurmond MC: Fluorescence-based multiplex real-time RT-PCR arrays
for the detection and serotype determination of foot-and-mouth
disease virus. J Virol Methods. 161:183–191. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang XQ, Ng RK, Ming X, Zhang W, Chen L,
Chu AC, Pang R, Lo CM, Tsao SW, Liu X, et al: Epigenetic regulation
of pluripotent genes mediates stem cell features in human
hepatocellular carcinoma and cancer cell lines. PLoS One.
8:e724352013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Setoguchi T, Taga T and Kondo T: Cancer
stem cells persist in many cancer cell lines. Cell Cycle.
3:414–415. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nakai-Futatsugi Y and Niwa H:
Transcription factor network in embryonic stem cells: Heterogeneity
under the stringency. Biol Pharm Bull. 36:166–170. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu G, Wilson G, Zhou G, Hebbard L, George
J and Qiao L: Oct4 is a reliable marker of liver tumor propagating
cells in hepatocellular carcinoma. Discov Med. 20:219–229.
2015.PubMed/NCBI
|
|
18
|
Zhu P, Wang Y, He L, Huang G, Du Y, Zhang
G, Yan X, Xia P, Ye B, Wang S, et al: ZIC2-dependent OCT4
activation drives self-renewal of human liver cancer stem cells. J
Clin Invest. 125:3795–3808. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chang TS, Wu YC, Chi CC, Su WC, Chang PJ,
Lee KF, Tung TH, Wang J, Liu JJ, Tung SY, et al: Activation of
IL6/IGFIR confers poor prognosis of HBV-related hepatocellular
carcinoma through induction of OCT4/NANOG expression. Clin Cancer
Res. 21:201–210. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao Y, Kong C, Chen X, Wang Z, Wan Z, Jia
L, Liu Q, Wang Y, Li W, Cui J, et al: Repetitive exposure to
low-dose X-irradiation attenuates testicular apoptosis in type 2
diabetic rats, likely via Akt-mediated Nrf2 activation. Mol Cell
Endocrinol. 422:203–210. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao RC, Zhou J, Chen KF, Gong J, Liu J,
He JY, Guan P, Li B and Qin Y: The prognostic value of combination
of CD90 and OCT4 for hepatocellular carcinoma after curative
resection. Neoplasma. 63:288–298. 2016.PubMed/NCBI
|
|
22
|
Murakami S, Ninomiya W, Sakamoto E,
Shibata T, Akiyama H and Tashiro F: SRY and OCT4 are required for
the acquisition of cancer stem cell-like properties and are
potential differentiation therapy targets. Stem Cells.
33:2652–2663. 2015. View Article : Google Scholar : PubMed/NCBI
|
